Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 4/2021

01-04-2021 | Tremor | Movement Disorders (T. Simuni, Section Editor)

Digital Technology in Movement Disorders: Updates, Applications, and Challenges

Authors: Jamie L. Adams, Karlo J. Lizarraga, Emma M. Waddell, Taylor L. Myers, Stella Jensen-Roberts, Joseph S. Modica, Ruth B. Schneider

Published in: Current Neurology and Neuroscience Reports | Issue 4/2021

Login to get access

Abstract

Purpose of Review

Digital technology affords the opportunity to provide objective, frequent, and sensitive assessment of disease outside of the clinic environment. This article reviews recent literature on the application of digital technology in movement disorders, with a focus on Parkinson’s disease (PD) and Huntington’s disease.

Recent Findings

Recent research has demonstrated the ability for digital technology to discriminate between individuals with and without PD, identify those at high risk for PD, quantify specific motor features, predict clinical events in PD, inform clinical management, and generate novel insights.

Summary

Digital technology has enormous potential to transform clinical research and care in movement disorders. However, more work is needed to better validate existing digital measures, including in new populations, and to develop new more holistic digital measures that move beyond motor features.
Literature
1.
2.
Grossman SN, Han SC, Balcer LJ, Kurzweil A, Weinberg H, Galetta SL, et al. Rapid implementation of virtual neurology in response to the COVID-19 pandemic. Neurology. 2020;94:1077–87.PubMedCrossRef
3.
Padala PR, Jendro AM, Gauss CH, Orr LC, Dean KT, Wilson KB, et al. Participant and caregiver perspectives on clinical research during Covid-19 pandemic. J Am Geriatr Soc. 2020;68:E14–8.PubMedCrossRef
4.
Papa SM, Brundin P, Fung VSC, Kang UJ, Burn DJ, Colosimo C, et al. Impact of the COVID-19 pandemic on Parkinson’s disease and movement disorders. Mov Disord. 2020;35:711–5.PubMedCrossRefPubMedCentral
5.
6.
Botros A, Schütz N, Camenzind M, Urwyler P, Bolliger D, Vanbellingen T, et al. Long-term home-monitoring sensor technology in patients with Parkinson’s disease-acceptance and adherence. Sensors (Basel, Switzerland). 2019;19:5169.CrossRef
7.
Silva de Lima AL, Hahn T, Evers LJW, de Vries NM, Cohen E, Afek M, et al. Feasibility of large-scale deployment of multiple wearable sensors in Parkinson’s disease. PLoS One. 2017;12:e0189161.PubMedPubMedCentralCrossRef
8.
Lee W, Evans A, Williams DR. Validation of a smartphone application measuring motor function in Parkinson’s disease. J Parkinsons Dis. 2016;6:371–82.PubMedCrossRef
9.
Bot BM, Suver C, Neto EC, Kellen M, Klein A, Bare C, et al. The mPower study, Parkinson disease mobile data collected using ResearchKit. Sci Data. 2016;3:160011.PubMedPubMedCentralCrossRef
10.
Espay AJ, Hausdorff JM, Sanchez-Ferro A, Klucken J, Merola A, Bonato P, et al. A roadmap for implementation of patient-centered digital outcome measures in Parkinson’s disease obtained using mobile health technologies. Mov Disord. 2019;34:657–63.PubMedPubMedCentralCrossRef
11.
Badawy R, Hameed F, Bataille L, Little MA, Claes K, Saria S, et al. Metadata concepts for advancing the use of digital health technologies in clinical research. Digit Biomark. 2019;3:116–32.PubMedPubMedCentralCrossRef
12.
Lamont RM, Daniel HL, Payne CL, Brauer SG. Accuracy of wearable physical activity trackers in people with Parkinson’s disease. Gait Posture. 2018;63:104–8.PubMedCrossRef
13.
Pradhan S, Kelly VE. Quantifying physical activity in early Parkinson disease using a commercial activity monitor. Parkinsonism Relat Disord. 2019;66:171–5.PubMedPubMedCentralCrossRef
14.
Kabelac Z, Tarolli CG, Snyder C, Feldman B, Glidden A, Hsu CY, et al. Passive monitoring at home: a pilot study in Parkinson disease. Digit Biomark. 2019;3:22–30.PubMedPubMedCentralCrossRef
15.
Mehrang S, Jauhiainen M, Pietil J, Puustinen J, Ruokolainen J, Nieminen H. Identification of Parkinson’s disease utilizing a single self-recorded 20-step walking test acquired by smartphone’s inertial measurement unit. Conf Proc IEEE Eng Med Biol Soc. 2018;2018:2913–6.
16.
Prince J, de Vos M. A deep learning framework for the remote detection of Parkinson’s disease using smart-phone sensor data. Conf Proc IEEE Eng Med Biol Soc. 2018;2018:3144–7.
17.
•• Lipsmeier F, Taylor KI, Kilchenmann T, Wolf D, Scotland A, Schjodt-Eriksen J, et al. Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson’s disease clinical trial. Mov Disord. 2018;33:1287–97 The authors describes the deployment of a smartphone application in a PD clinical trial and demonstrate the test-retest reliability and sensitivity of smartphone assessments, their ability to discriminate between PD and healthy controls, and the potential to generate novel insights.PubMedPubMedCentralCrossRef
18.
Di Lazzaro G, Ricci M, Al-Wardat M, Schirinzi T, Scalise S, Giannini F, et al. Technology-based objective measures detect subclinical axial signs in untreated, de novo Parkinson’s disease. J Parkinsons Dis. 2020;10:113–22.PubMedCrossRef
19.
Mc Ardle R, Del Din S, Galna B, Thomas A, Rochester L. Differentiating dementia disease subtypes with gait analysis: feasibility of wearable sensors? Gait Posture. 2020;76:372–6.PubMedCrossRef
20.
De Vos M, Prince J, Buchanan T, FitzGerald JJ, Antoniades CA. Discriminating progressive supranuclear palsy from Parkinson’s disease using wearable technology and machine learning. Gait Posture. 2020;77:257–63.PubMedCrossRef
21.
Barrantes S, Sanchez Egea AJ, Gonzalez Rojas HA, Marti MJ, Compta Y, Valldeoriola F, et al. Differential diagnosis between Parkinson’s disease and essential tremor using the smartphone’s accelerometer. PLoS One. 2017;12:e0183843.PubMedPubMedCentralCrossRef
22.
di Biase L, Brittain J-S, Shah SA, Pedrosa DJ, Cagnan H, Mathy A, Chen CC, Martín-Rodríguez JF, Mir P, Timmerman L, Schwingenschuh P, Bhatia K, Di Lazzaro V, Brown P (2017) Tremor stability index: a new tool for differential diagnosis in tremor syndromes. Brain: a journal of neurology 140, 1977-1986.
23.
Fereshtehnejad SM, Yao C, Pelletier A, Montplaisir JY, Gagnon JF, Postuma RB. Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study. Brain. 2019;142:2051–67.PubMedCrossRef
24.
• Arora S, Baig F, Lo C, Barber TR, Lawton MA, Zhan A, et al. Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD. Neurology. 2018;91:e1528–38 The authors demonstrate the ability for smartphone tests to discriminat between PD, healthy controls, and idiopathic REM sleep behavior disorder with a high degree of accuracy.PubMedPubMedCentralCrossRef
25.
Singh S, Xu W. Robust detection of Parkinson’s disease using harvested smartphone voice data: a telemedicine approach. Telemed J E Health. 2020;26:327–34.PubMedPubMedCentralCrossRef
26.
Zhang YN. Can a smartphone diagnose Parkinson disease? A deep neural network method and telediagnosis system implementation. Parkinsons Dis. 2017;2017:6209703.PubMedPubMedCentral
27.
Rusz J, Hlavnicka J, Tykalova T, Novotny M, Dusek P, Sonka K, et al. Smartphone allows capture of speech abnormalities associated with high risk of developing Parkinson's disease. IEEE Trans Neural Syst Rehabil Eng. 2018;26:1495–507.PubMedCrossRef
28.
• Del Din S, Elshehabi M, Galna B, Hobert MA, Warmerdam E, Suenkel U, et al. Gait analysis with wearables predicts conversion to Parkinson disease. Ann Neurol. 2019;86:357–67 In a large cohort of older adults, the authors identified wearable sensor-derived gait features that predicted PD diagnosis.PubMedPubMedCentralCrossRef
29.
von Coelln R, Dawe RJ, Leurgans SE, Curran TA, Truty T, Yu L, et al. Quantitative mobility metrics from a wearable sensor predict incident parkinsonism in older adults. Parkinsonism Relat Disord. 2019;65:190–6.CrossRef
30.
Lalvay L, Lara M, Mora A, Alarcon F, Fraga M, Pancorbo J, et al. Quantitative measurement of akinesia in Parkinson’s disease. Mov Disord Clin Pract. 2017;4:316–22.PubMedCrossRef
31.
Ellis RJ, Ng YS, Zhu S, Tan DM, Anderson B, Schlaug G, et al. A validated smartphone-based assessment of gait and gait variability in Parkinson’s disease. PLoS One. 2015;10:e0141694.PubMedPubMedCentralCrossRef
32.
Fiems CL, Miller SA, Buchanan N, Knowles E, Larson E, Snow R, et al. Does a sway-based mobile application predict future falls in people with Parkinson disease? Arch Phys Med Rehabil. 2020;101:472–8.PubMedCrossRef
33.
Kim HB, Lee HJ, Lee WW, Kim SK, Jeon HS, Park HY, et al. Validation of freezing-of-gait monitoring using smartphone. Telemed J E Health. 2018;24:899–907.PubMedCrossRef
34.
Yahalom G, Yekutieli Z, Israeli-Korn S, Elincx-Benizri S, Livneh V, Fay-Karmon T, et al. Smartphone based timed up and go test can identify postural instability in Parkinson’s disease. Isr Med Assoc J. 2020;22:37–42.PubMed
35.
Hobert MA, Nussbaum S, Heger T, Berg D, Maetzler W, Heinzel S. Progressive gait deficits in Parkinson’s disease: a wearable-based biannual 5-year prospective study. Front Aging Neurosci. 2019;11:22.PubMedPubMedCentralCrossRef
36.
Suppa A, Kita A, Leodori G, Zampogna A, Nicolini E, Lorenzi P, et al. l-DOPA and freezing of gait in Parkinson’s disease: objective assessment through a wearable wireless system. Front Neurol. 2017;8:406.PubMedPubMedCentralCrossRef
37.
Haji Ghassemi N, Hannink J, Roth N, Gaßner H, Marxreiter F, Klucken J, Eskofier BM (2019) Turning analysis during standardized test using on-shoe wearable sensors in Parkinson’s disease. Sensors (Basel, Switzerland) 19, 3103.
38.
Silva de Lima AL, Smits T, Darweesh SKL, Valenti G, Milosevic M, Pijl M, et al. Home-based monitoring of falls using wearable sensors in Parkinson’s disease. Mov Disord. 2020;35:109–15.PubMedCrossRef
39.
Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, et al. A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord. 2007;22:1892–900.PubMedCrossRef
40.
• Lo C, Arora S, Baig F, Lawton MA, El Mouden C, Barber TR, et al. Predicting motor, cognitive & functional impairment in Parkinson’s. Ann Clin Transl Neurol. 2019;6:1498–509 The authors demonstrate that performance on smartphone tests can predict key clinical milestones at 18 months.PubMedPubMedCentral
41.
Jeon H, Lee W, Park H, Lee HJ, Kim SK, Kim HB, et al. High-accuracy automatic classification of Parkinsonian tremor severity using machine learning method. Physiol Meas. 2017;38:1980–99.PubMedCrossRef
42.
López-Blanco R, Velasco MA, Méndez-Guerrero A, Romero JP, Del Castillo MD, Serrano JI, et al. Smartwatch for the analysis of rest tremor in patients with Parkinson’s disease. J Neurol Sci. 2019;401:37–42.PubMedCrossRef
43.
Gatsios D, Antonini A, Gentile G, Marcante A, Pellicano C, Macchiusi L, et al. Feasibility and utility of mHealth for the remote monitoring of parkinson disease: randomized controlled trial. JMIR Mhealth Uhealth. 2020.
44.
Lee CY, Kang SJ, Hong SK, Ma HI, Lee U, Kim YJ. A validation study of a smartphone-based finger tapping application for quantitative assessment of bradykinesia in Parkinson’s disease. PLoS One. 2016;11:e0158852.PubMedPubMedCentralCrossRef
45.
Printy BP, Renken LM, Herrmann JP, Lee I, Johnson B, Knight E, et al. Smartphone application for classification of motor impairment severity in Parkinson’s disease. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:2686–9.
46.
Artusi CA, Mishra M, Latimer P, Vizcarra JA, Lopiano L, Maetzler W, et al. Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases. Parkinsonism Relat Disord. 2018;46(Suppl 1):S53–6.PubMedCrossRef
47.
Zhan A, Mohan S, Tarolli C, Schneider RB, Adams JL, Sharma S, et al. Using smartphones and machine learning to quantify Parkinson disease severity: the mobile Parkinson disease score. JAMA Neurol. 2018;75:876–80.PubMedPubMedCentralCrossRef
48.
Mantri S, Wood S, Duda JE, Morley JF. Comparing self-reported and objective monitoring of physical activity in Parkinson disease. Parkinsonism Relat Disord. 2019;67:56–9.PubMedCrossRef
49.
Galperin I, Hillel I, Del Din S, Bekkers EMJ, Nieuwboer A, Abbruzzese G, et al. Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson’s disease. Parkinsonism Relat Disord. 2019;62:85–90.PubMedCrossRef
50.
• Mirelman A, Hillel I, Rochester L, Del Din S, Bloem BR, Avanzino L, et al. Tossing and turning in bed: nocturnal movements in Parkinson’s disease. Mov Disord. 2020; The authors demonstrated that wearable devices can quanitfy nocturnal movements in PD and detect differences based on disease stage.
51.
Arroyo-Gallego T, Ledesma-Carbayo MJ, Sanchez-Ferro A, Butterworth I, Mendoza CS, Matarazzo M, et al. Detection of motor impairment in Parkinson’s disease via mobile touchscreen typing. IEEE Trans Biomed Eng. 2017;64:1994–2002.PubMedCrossRef
52.
Iakovakis D, Diniz JA, Trivedi D, Chaudhuri RK, Hadjileontiadis LJ, Hadjidimitriou S, et al. Early Parkinson’s disease detection via touchscreen typing analysis using convolutional neural networks. Conf Proc IEEE Eng Med Biol Soc. 2019;2019:3535–8.
53.
Iakovakis D, Hadjidimitriou S, Charisis V, Bostantzopoulou S, Katsarou Z, Hadjileontiadis LJ. Touchscreen typing-pattern analysis for detecting fine motor skills decline in early-stage Parkinson’s disease. Sci Rep. 2018;8:7663.PubMedPubMedCentralCrossRef
54.
Liddle J, Ireland D, McBride SJ, Brauer SG, Hall LM, Ding H, et al. Measuring the lifespace of people with Parkinson’s disease using smartphones: proof of principle. JMIR Mhealth Uhealth. 2014;2:e13.PubMedPubMedCentralCrossRef
55.
Liddle J, Sundraraj A, Ireland D, Bennett S, Stillerova T, Silburn P. Impact of deep brain stimulation on people with Parkinson’s disease: a mixed methods feasibility study exploring lifespace and community outcomes. Hong Kong J Occup Ther. 2019;32:97–107.PubMedPubMedCentralCrossRef
56.
Antonini A, Gentile G, Giglio M, Marcante A, Gage H, MML T, et al. Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial. Trials. 2018;19:492.PubMedPubMedCentralCrossRef
57.
Hssayeni MD, Burack MA, Jimenez-Shahed J, Ghoraani B. Assessment of response to medication in individuals with Parkinson’s disease. Med Eng Phys. 2019;67:33–43.PubMedCrossRef
58.
Vizcarra JA, Sanchez-Ferro A, Maetzler W, Marsili L, Zavala L, Lang AE, et al. The Parkinson’s disease e-diary: developing a clinical and research tool for the digital age. Mov Disord. 2019;34:676–81.PubMedCrossRefPubMedCentral
59.
Lopane G, Mellone S, Corzani M, Chiari L, Cortelli P, Calandra-Buonaura G, et al. Supervised versus unsupervised technology-based levodopa monitoring in Parkinson’s disease: an intrasubject comparison. J Neurol. 2018;265:1343–52.PubMedCrossRef
60.
Lee W, Evans AH, Williams DR. Objective measurement and characterization of sleep benefit in Parkinson’s disease. Mov Disord Clin Pract. 2017;4:590–6.PubMedPubMedCentralCrossRef
61.
Isaacson SH, Boroojerdi B, Waln O, McGraw M, Kreitzman DL, Klos K, et al. Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson’s disease starting transdermal rotigotine patch: a pilot study. Parkinsonism Relat Disord. 2019;64:132–7.PubMedCrossRef
62.
Joshi R, Bronstein JM, Keener A, Alcazar J, Yang DD, Joshi M, et al. PKG movement recording system use shows promise in routine clinical care of patients with Parkinson’s disease. Front Neurol. 2019;10:1027.PubMedPubMedCentralCrossRef
63.
Elm JJ, Daeschler M, Bataille L, Schneider R, Amara A, Espay AJ, et al. Feasibility and utility of a clinician dashboard from wearable and mobile application Parkinson’s disease data. NPJ Digit Med. 2019;2:95.PubMedPubMedCentralCrossRef
64.
65.
Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Galtrey C, Guzman NV, et al. Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease. NPJ Parkinsons Dis. 2017;3:2.PubMedPubMedCentralCrossRef
66.
Horin AP, McNeely ME, Harrison EC, Myers PS, Sutter EN, Rawson KS, et al. Usability of a daily mHealth application designed to address mobility, speech and dexterity in Parkinson’s disease. Neurodegener Dis Manag. 2019;9:97–105.PubMedPubMedCentralCrossRef
67.
Fung A, Lai EC, Lee BC. Usability and validation of the smarter balance system: an unsupervised dynamic balance exercises system for individuals with Parkinson’s disease. IEEE Trans Neural Syst Rehabil Eng. 2018;26:798–806.PubMedCrossRef
68.
Balachandar A, Fasano A. Characterizing orthostatic tremor using a smartphone application. Tremor Other Hyperkinet Mov (N Y). 2017;7:488.CrossRef
69.
Chien JH, Torres-Russotto D, Wang Z, Gui C, Whitney D, Siu KC. The use of smartphone in measuring stance and gait patterns in patients with orthostatic tremor. PLoS One. 2019;14:e0220012.PubMedPubMedCentralCrossRef
70.
Yahalom H, Israeli-Korn S, Linder M, Yekutieli Z, Karlinsky KT, Rubel Y, et al. Psychiatric patients on neuroleptics: evaluation of parkinsonism and quantified assessment of gait. Clin Neuropharmacol. 2020;43:1–6.PubMedCrossRef
71.
Gordon MF, Grachev ID, Mazeh I, Dolan Y, Reilmann R, Loupe PS, et al. Quantification of motor function in Huntington disease patients using wearable sensor devices. Digit Biomark. 2019;3:103–15.PubMedPubMedCentralCrossRef
72.
Adams JL, Waddell EM, Dinesh K, Spear KL, Tarolli CG, Elson MJ, et al. GEORGE® – The first smartphone application for Huntington disease: a pilot study (4467). Neurology. 2020;94(15 supplement):4467.
73.
Purcell NL, Goldman JG, Ouyang B, Bernard B, O'Keefe JA. The effects of dual-task cognitive interference and environmental challenges on balance in Huntington’s disease. Mov Disord Clin Pract. 2019;6:202–12.PubMedPubMedCentralCrossRef
74.
Kegelmeyer DA, Kostyk SK, Fritz NE, Fiumedora MM, Chaudhari A, Palettas M, et al. Quantitative biomechanical assessment of trunk control in Huntington’s disease reveals more impairment in static than dynamic tasks. J Neurol Sci. 2017;376:29–34.PubMedCrossRef
75.
Dinesh K, Snyder CW, Xiong M, Tarolli CG, Sharma S, Dorsey ER, et al. A longitudinal wearable sensor study in Huntington’s disease. Journal of Huntington's Disease. 2020;9:69–81.PubMedCrossRef
76.
Nguyen N, Phan D, Pathirana PN, Horne M, Power L, Szmulewicz D. Quantification of axial abnormality due to cerebellar ataxia with inertial measurements. Sensors (Basel, Switzerland). 2018;18:2791.CrossRef
77.
Caliandro P, Conte C, Iacovelli C, Tatarelli A, Castiglia SF, Reale G, et al. Exploring risk of falls and dynamic unbalance in cerebellar ataxia by inertial sensor assessment. Sensors (Basel, Switzerland). 2019;19:5571.CrossRef
78.
López-Blanco R, Velasco MA, Méndez-Guerrero A, Romero JP, del Castillo MD, Serrano JI, et al. Essential tremor quantification based on the combined use of a smartphone and a smartwatch: the NetMD study. J Neurosci Methods. 2018;303:95–102.PubMedCrossRef
79.
Zheng X, Vieira Campos A, Ordieres-Meré J, Balseiro J, Labrador Marcos S, Aladro Y. Continuous monitoring of essential tremor using a portable system based on smartwatch. Front Neurol. 2017;8:96.PubMedPubMedCentralCrossRef
80.
Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 2003;349:1925–34.PubMedCrossRef
81.
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368:610–22.PubMedCrossRef
82.
Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 1991;337:403–6.PubMedCrossRef
83.
Moro E, LeReun C, Krauss JK, Albanese A, Lin JP, Walleser Autiero S, et al. Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta-analysis. Eur J Neurol. 2017;24:552–60.PubMedPubMedCentralCrossRef
84.
Heldman DA, Giuffrida JP, Cubo E. Wearable sensors for advanced therapy referral in Parkinson’s disease. J Parkinsons Dis. 2016;6:631–8.PubMedCrossRef
85.
Lieber B, Taylor BE, Appelboom G, McKhann G, Connolly ES Jr. Motion sensors to assess and monitor medical and surgical management of Parkinson disease. World Neurosurg. 2015;84:561–6.PubMedCrossRef
86.
Chockalingam A, Boggs H, Prusik J, Ramirez-Zamora A, Feustel P, Belasen A, et al. Evaluation of quantitative measurement techniques for head tremor with thalamic deep brain stimulation. Neuromodulation. 2017;20:464–70.PubMedCrossRef
87.
Wang J, Gong D, Zhang W, Zhang H, Wang S. Quantifying the influence of DBS surgery in patients with Parkinson’s disease during perioperative period by wearable sensors. Conf Proc IEEE Eng Med Biol Soc. 2019;2019:3311–4.
88.
Lopes EM, Vilas-Boas MDC, Dias D, Rosas MJ, Vaz R, Cunha JPS. iHandU: a novel quantitative wrist rigidity evaluation device for deep brain stimulation surgery. Sensors (Basel). 2020;20:331.CrossRef
89.
Swann NC, de Hemptinne C, Thompson MC, Miocinovic S, Miller AM, Gilron R, et al. Adaptive deep brain stimulation for Parkinson’s disease using motor cortex sensing. J Neural Eng. 2018;15:046006.PubMedPubMedCentralCrossRef
90.
Herron JA, Thompson MC, Brown T, Chizeck HJ, Ojemann JG, Ko AL. Chronic electrocorticography for sensing movement intention and closed-loop deep brain stimulation with wearable sensors in an essential tremor patient. J Neurosurg. 2017;127:580–7.PubMedCrossRef
91.
Arlotti M, Marceglia S, Foffani G, Volkmann J, Lozano AM, Moro E, et al. Eight-hours adaptive deep brain stimulation in patients with Parkinson disease. Neurology. 2018;90:e971–6.PubMedPubMedCentralCrossRef
92.
Pina-Fuentes D, Little S, Oterdoom M, Neal S, Pogosyan A, Tijssen MAJ, et al. Adaptive DBS in a Parkinson’s patient with chronically implanted DBS: a proof of principle. Mov Disord. 2017;32:1253–4.PubMedPubMedCentralCrossRef
93.
Little S, Tripoliti E, Beudel M, Pogosyan A, Cagnan H, Herz D, et al. Adaptive deep brain stimulation for Parkinson’s disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting. J Neurol Neurosurg Psychiatry. 2016;87:1388–9.PubMedCrossRef
94.
Tinkhauser G, Pogosyan A, Tan H, Herz DM, Kuhn AA, Brown P. Beta burst dynamics in Parkinson’s disease OFF and ON dopaminergic medication. Brain. 2017;140:2968–81.PubMedCrossRef
95.
Rosa M, Arlotti M, Marceglia S, Cogiamanian F, Ardolino G, Fonzo AD, et al. Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients. Mov Disord. 2017;32:628–9.PubMedPubMedCentralCrossRef
96.
Piña-Fuentes D, Beudel M, Van Zijl JC, Van Egmond ME, Oterdoom DLM, Van Dijk JMC, et al. Low-frequency oscillation suppression in dystonia: implications for adaptive deep brain stimulation. Parkinsonism Relat Disord. 2020;79:105–9.PubMedCrossRef
97.
Liu Z, Liu Y, Wan X, Yang Y, Wang L, Dou W, et al. Pallidal deep brain stimulation in patients with chorea-acanthocytosis. Neuromodulation. 2018;21:741–7.PubMedCrossRef
98.
Fasano A, Mancini M. Wearable-based mobility monitoring: the long road ahead. Lancet Neurol. 2020;19:378–9.PubMedCrossRef
99.
Warmerdam E, Hausdorff JM, Atrsaei A, Zhou Y, Mirelman A, Aminian K, et al. Long-term unsupervised mobility assessment in movement disorders. Lancet Neurol. 2020;19:462–70.PubMedCrossRef
100.
Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, Group NV. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord. 2011;26:399–406.PubMedCrossRef
101.
Santos-Garcia D, de la Fuente-Fernandez R. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson’s disease. J Neurol Sci. 2013;332:136–40.PubMedCrossRef
102.
Prakash KM, Nadkarni NV, Lye WK, Yong MH, Tan EK. The impact of non-motor symptoms on the quality of life of Parkinson’s disease patients: a longitudinal study. Eur J Neurol. 2016;23:854–60.PubMedCrossRef
103.
104.
105.
Norris P (2001) Digital Divide: Civic Engagement, Information Poverty, and the Internet Worldwide, Cambridge University Press, Cambridge.
106.
Cohen S, Waks Z, Elm JJ, Gordon MF, Grachev ID, Navon-Perry L, et al. Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease. BMC Med Inform Decis Mak. 2018;18:138.PubMedPubMedCentralCrossRef
107.
Fan X, Wang D, Hellman B, Janssen MF, Bakker G, Coghlan R, et al. Assessment of health-related quality of life between people with Parkinson’s disease and non-Parkinson’s: using data drawn from the ‘100 for Parkinson’s’ smartphone-based prospective study. Int J Environ Res Public Health. 2018;15.
108.
Schneider RB AS, Myers T, Kayson E, Omberg L, Tarolli C, Daeschler M, Macklin E, Dorsey ER, Mangravite L, Schwarzschild M, Simuni T (2019) in International Congress of Parkinson’s Disease and Movement Disorders Nice, France.
109.
Malekmohammadi M, Shahriari Y, AuYong N, O'Keeffe A, Bordelon Y, Hu X, et al. Pallidal stimulation in Parkinson disease differentially modulates local and network beta activity. J Neural Eng. 2018;15:056016.PubMedPubMedCentralCrossRef
110.
Hell F, Plate A, Mehrkens JH, Botzel K. Subthalamic oscillatory activity and connectivity during gait in Parkinson’s disease. Neuroimage Clin. 2018;19:396–405.PubMedPubMedCentralCrossRef
111.
Canessa A, Pozzi NG, Arnulfo G, Brumberg J, Reich MM, Pezzoli G, et al. Striatal dopaminergic innervation regulates subthalamic beta-oscillations and cortical-subcortical coupling during movements: preliminary evidence in subjects with Parkinson’s disease. Front Hum Neurosci. 2016;10:611.PubMedPubMedCentralCrossRef
112.
Panov F, Levin E, de Hemptinne C, Swann NC, Qasim S, Miocinovic S, et al. Intraoperative electrocorticography for physiological research in movement disorders: principles and experience in 200 cases. J Neurosurg. 2017;126:122–31.PubMedCrossRef
113.
Metadata
Title
Digital Technology in Movement Disorders: Updates, Applications, and Challenges
Authors
Jamie L. Adams
Karlo J. Lizarraga
Emma M. Waddell
Taylor L. Myers
Stella Jensen-Roberts
Joseph S. Modica
Ruth B. Schneider
Publication date
01-04-2021
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 4/2021
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-021-01101-6

Other articles of this Issue 4/2021

Current Neurology and Neuroscience Reports 4/2021 Go to the issue

Movement Disorders (T. Simuni, Section Editor)

The Role of Genetic Testing for Parkinson’s Disease

Demyelinating Disorders (J. Bernard and M. Cameron, Section Editors)

Telehealth in Multiple Sclerosis Clinical Care and Research

Autonomic Dysfunction (L.H. Weimer, Section Editor)

Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension

Genetics (E.M. Valente, Section Editor)

Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic Paraplegia